SKTO — SK3 Group, Inc.
$0.00
+$0.00 (+0.00%)
SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California. It licenses various products for marketing and sale, including the YAK line of medical marijuana edibles; Canna-Loz, a delivery system for large doses of phyto-cannabinoids; Yeti, a pre-roll for pain relief; and Dharmanol, a proprietary technology that extracts, stabilizes, and preserves the medicinal cannabinoids found in hemp and marijuana in their non-psychoactive form.
Market Cap
$1.52M
Forward P/E
N/A
52-Week Range
N/A
SKTO Price History
Revenue vs. Net Income
$8M
Revenue · FY2010
Annual. Net margin is shown under each year.
Free Cash Flow
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
152.23B
Diluted shares · FY2010
Only one year of share data is available, so no change can be shown yet.
